11 Best Dividend Paying Stocks to Buy According to Hedge Funds
Dividend-paying stocks have consistently attracted investor interest due to their long-term value. CNBC highlights this by examining the historical performance of the broader market.
Johnson & Johnson (JNJ)
Market is closed
Sector: Pharmaceutical Preparations
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | Lee Munder Capital Group Lee Munder | 48,836 | $8,098,962 | +106% | 0.54% |
| 2. | Bourgeon Capital John Zaro | 5,241 | $869,168 | +1% | 0.19% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $145.53 | 100 | Director | 250 | 2024-04-30 | Filing | |
| $147.22 | 1,000 | Director | 1,000 | 2024-12-12 | Filing | |
| $127.69 | 500 | Director | 16,030 | 2020-03-13 | Filing | |
| $141.28 | 5,000 | Director | 5,000 | 2019-12-13 | Filing | |
| $139.68 | 3,000 | Director | 3,000 | 2019-06-11 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $165.88 | 6,999 | Officer | 21,001 | 2025-02-25 | Filing | |
| $156.15 | 403 | Officer | 15,098 | 2025-02-18 | Filing | |
| $153.89 | 13,015 | Officer | 0 | 2025-02-07 | Filing | |
| $165.06 | 5,635 | Officer | 18,973 | 2024-08-30 | Filing | |
| $162.16 | 8,891 | Officer | 15,043 | 2024-03-13 | Filing |
Institutional Investors' Holdings
Filing Period:
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 4,158,076 | $689,575,237 | 0.65% | |
| 2. | 617,675 | $102,435,251 | 1.51% | |
| 3. | 564,807 | $93,667,593 | 1.08% | |
| 4. | 552,976 | $91,705,540 | 0.84% | |
| 5. | 405,364 | $67,225,566 | 1.04% |
News See All
Jim Cramer Questions Market Logic and Dissects These 7 Key Stocks
In his latest appearance on CNBC’s Squawk on the Street, Jim Cramer unpacked the deepening uncertainty gripping both markets and politics as investors brace for higher inflation, elevated yields, ...
11 Cheap NYSE Stocks to Invest in According to Hedge Funds
On March 26, Jack Caffrey of JPMorgan Asset Management provided an analysis of market trends in a discussion on CNBC's 'Squawk Box'.
10 Best Medical Stocks to Buy According to Billionaires
Some experts view medical, healthcare, and big pharma stocks as immune from trade carnage, making them a safe haven amid the uncertainty brought about by Trump's tariffs.
Jim Cramer Says Tariff Pain Isn’t Over Yet And Reviews These 9 Stocks
In his latest appearance on CNBC’s Squawk on the Street, Jim Cramer dissected the market’s recent rally and reminded his viewers to not mistake short-term optimism for resolution.
10 Defensive Stocks Billionaire Ken Fisher Is Betting On
Ken Fisher, an American billionaire investor, author, and financial analyst, founded and runs Fisher Asset Management.
Jim Cramer's Hidden Market Sectors Amidst Tariffs & 8 Stocks
On his appearance on CNBC's Squawk on the Street on Thursday, Jim Cramer commented on the global response to President Trump's tariffs.
10 Best Healthcare Stocks to Buy According to Billionaires
Healthcare stocks experienced a challenging year in 2024, lagging behind high-growth sectors like tech and AI.
15 Best Dividend Aristocrat Stocks with Over 3% Yield
Dividend Aristocrats are the companies that have raised their payouts for 25 consecutive years or more. Dividends have been an important part of the overall market return for a very long time.
Jim Cramer Says Trump's Tariff Strategy Is Working & Discusses These 11 Stocks
In a recent appearance on CNBC's Squawk on the Street, Jim Cramer discussed the outcomes of President Trump's tariffs and whether Trump is hostile to the markets.
Billionaire Hedge Funds
